Eli Lilly & Co.
(NYSE : LLY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-6.21%127.720.7%$1062.40m
MRKMerck & Co., Inc.
1.07%84.700.7%$636.75m
PFEPfizer Inc.
0.00%36.460.9%$629.75m
ABBVAbbVie, Inc.
1.77%76.472.3%$578.88m
BMYBristol-Myers Squibb Company
1.15%53.021.4%$522.05m
LLYEli Lilly and Company
0.16%108.631.0%$298.35m
NVSNovartis AG Sponsored ADR
-0.39%86.890.2%$144.58m
AZNAstraZeneca PLC Sponsored ADR
-0.59%43.871.2%$133.90m
GSKGlaxoSmithKline plc Sponsored ADR
0.12%42.520.2%$97.15m
SNYSanofi Sponsored ADR
-0.71%46.170.2%$75.70m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.29%52.530.1%$68.10m
LCILannett Company, Inc.
-1.84%11.7335.6%$15.44m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.87%1.691.6%$0.44m
EPIXESSA Pharma Inc
8.79%3.900.1%$0.11m

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.